Frailty, Hip Fractures and Inflammatory Biomarkers

NCT ID: NCT06614478

Last Updated: 2024-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty Hip Fracture Inflammatory Biomarkers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hip fracture patients treated with surgery

Hip fracture patients treated with surgery. Frailty will be categorized based on the validated Groningen Frailty Indicator (GFI)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients

Exclusion Criteria

* Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Thessaly

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elena Arnaoutoglou

Chair, Professor of Anaesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eleni Arnaoutoglou, Professor

Role: STUDY_CHAIR

University of Thessaly

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Larissa University Hospital

Larissa, Thessaly, Greece

Site Status RECRUITING

UHL

Larissa, Thessaly, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eleni Arnaoutoglou, Professor

Role: CONTACT

+302413502952

Maria Ntalouka, MD, PhD, Mac

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eleni Arnaoutoglou, Professor

Role: primary

030241302952

Eleni Arnaoutoglou, Professor

Role: primary

+30241302952

Maria Ntalouka, MD, PhD, Mac

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Frailty and hip fractures

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.